ROBERT BUKA

Robert Buka is a Product Director for the Acorn AI Intelligent Trials portfolio. He leads Acorn’s Study Feasibility product, which helps pharmaceutical sponsors and CROs use historical data and predictive algorithms to properly plan and execute their clinical trials to achieve study accrual targets. Robert has over 9 years of technology industry experience leading data science teams and delivering digital transformation projects. Robert studied Biology and Statistics at the University of Pennsylvania.